Toursyn Intelligence has recently completed consecutive Pre-A and Pre-A+ financing rounds, raising a combined total of several hundred million yuan. The Pre-A round was led by Shanghai Sci-Tech Group, with participation from Zhongsheng Yinling, Zhoushan Tuyi, and others. The Pre-A+ round was jointly invested by Jinding Capital, MegaRobo Technologies, Zero2IPO Holdings, and others. Kaicheng Capital serves as the long-term exclusive financial advisor. The proceeds will be primarily used to accelerate the advancement of the company's self-developed pipelines, continuously upgrade the ToursynClaw one-stop AI drug design platform, and strengthen team operations and market expansion.
